Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SupplySide West In Brief

This article was originally published in The Tan Sheet

Executive Summary

NDI guidance not a disaster for probiotics

You may also be interested in...

Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

NDI Guidance Microorganism Stance Could Strain Probiotics Development

The growth of probiotics in supplements could slow to a crawl under FDA's new dietary ingredient notification draft guidance, industry stakeholders fear.

GMP Inspectors Find "Dismal" Compliance, Smell "Blood In The Water"

FDA inspectors are finding "pretty dismal" compliance across the board with dietary supplement good manufacturing practices and are going after violations "like a shark to blood in the water," an agency official says.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts